Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Smerage is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2001 - 2004
University of Virginia Medical CenterResidency, Internal Medicine, 1998 - 2001
University of Florida College of MedicineClass of 1998
Certifications & Licensure
MI State Medical License 2001 - 2026
VA State Medical License 1998 - 2002
American Board of Internal Medicine Medical Oncology
American Board of Preventive Medicine Clinical Informatics
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer Start of enrollment: 2005 Apr 01
- S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo Start of enrollment: 2006 Oct 01
Publications & Presentations
PubMed
- Clinical validity of repeated circulating tumor cell enumeration as an early treatment monitoring tool for metastatic breast cancer in the PREDICT global pooled analysis.Wolfgang Janni, Thomas W P Friedl, Tracy C Yab, Francois-Clément Bidard, Massimo Cristofanilli
Clinical Cancer Research. 2025-03-18 - 5 citationsGetting ready for real-world use of electronic patient-reported outcomes (ePROs) for patients with cancer: A National Comprehensive Cancer Network ePRO Workgroup paper.Jennifer R Cracchiolo, Waddah Arafat, Ashish Atreja, Lauren Bruckner, Hamid Emamekhoo
Cancer. 2023-08-15 - 9 citationsTumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer.Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga
JCO Precision Oncology. 2023-01-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
